US Patent Issued to Deciphera Pharmaceuticals on Oct. 21 for "Formulations of vimseltinib" (Massachusetts Inventor)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,149, issued on Oct. 21, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.).

"Formulations of vimseltinib" was invented by Ehab Hamed (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein, in part, are pharmaceutically acceptable formulations comprising a compound represented by Formula (I) and methods of preparing and using the formulations:"

The patent was filed on March 13, 2025, under Application No. 19/079,070.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50...